BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 29205106)

  • 1. Differential Expression of Cholinergic System Components in Human Induced Pluripotent Stem Cells, Bone Marrow-Derived Multipotent Stromal Cells, and Induced Pluripotent Stem Cell-Derived Multipotent Stromal Cells.
    Weist R; Flörkemeier T; Roger Y; Franke A; Schwanke K; Zweigerdt R; Martin U; Willbold E; Hoffmann A
    Stem Cells Dev; 2018 Feb; 27(3):166-183. PubMed ID: 29205106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells Are Functionally and Genetically Different From Bone Marrow-Derived Mesenchymal Stromal Cells.
    Xu M; Shaw G; Murphy M; Barry F
    Stem Cells; 2019 Jun; 37(6):754-765. PubMed ID: 30779868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cells.
    Chen YS; Pelekanos RA; Ellis RL; Horne R; Wolvetang EJ; Fisk NM
    Stem Cells Transl Med; 2012 Feb; 1(2):83-95. PubMed ID: 23197756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the anti-inflammatory effects of induced pluripotent stem cell-derived and bone marrow-derived mesenchymal stromal cells in a murine model of corneal injury.
    Yun YI; Park SY; Lee HJ; Ko JH; Kim MK; Wee WR; Reger RL; Gregory CA; Choi H; Fulcher SF; Prockop DJ; Oh JY
    Cytotherapy; 2017 Jan; 19(1):28-35. PubMed ID: 27840134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation and differentiation of induced pluripotent stem cells reveal ankylosing spondylitis risk gene expression in bone progenitors.
    Layh-Schmitt G; Lu S; Navid F; Brooks SR; Lazowick E; Davis KM; Montagna C; Gadina M; Colbert RA
    Clin Rheumatol; 2017 Jan; 36(1):143-154. PubMed ID: 27864696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells derived from human induced pluripotent stem cells retain adequate osteogenicity and chondrogenicity but less adipogenicity.
    Kang R; Zhou Y; Tan S; Zhou G; Aagaard L; Xie L; Bünger C; Bolund L; Luo Y
    Stem Cell Res Ther; 2015 Aug; 6(1):144. PubMed ID: 26282538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insensitivity of Human iPS Cells-Derived Mesenchymal Stem Cells to Interferon-γ-induced HLA Expression Potentiates Repair Efficiency of Hind Limb Ischemia in Immune Humanized NOD Scid Gamma Mice.
    Sun YQ; Zhang Y; Li X; Deng MX; Gao WX; Yao Y; Chiu SM; Liang X; Gao F; Chan CW; Tse HF; Shi J; Fu QL; Lian Q
    Stem Cells; 2015 Dec; 33(12):3452-67. PubMed ID: 26175298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells.
    Pfaff N; Lachmann N; Kohlscheen S; Sgodda M; Araúzo-Bravo MJ; Greber B; Kues W; Glage S; Baum C; Niemann H; Schambach A; Cantz T; Moritz T
    Stem Cells Dev; 2012 Mar; 21(5):689-701. PubMed ID: 21732815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of mesenchymal stem cells from human induced pluripotent stem cells on differentiation, maturation, and function of dendritic cells.
    Gao WX; Sun YQ; Shi J; Li CL; Fang SB; Wang D; Deng XQ; Wen W; Fu QL
    Stem Cell Res Ther; 2017 Mar; 8(1):48. PubMed ID: 28253916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Directed Differentiation of Human-Induced Pluripotent Stem Cells to Mesenchymal Stem Cells.
    Lian Q; Zhang Y; Liang X; Gao F; Tse HF
    Methods Mol Biol; 2016; 1416():289-98. PubMed ID: 27236679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MSCs derived from iPSCs with a modified protocol are tumor-tropic but have much less potential to promote tumors than bone marrow MSCs.
    Zhao Q; Gregory CA; Lee RH; Reger RL; Qin L; Hai B; Park MS; Yoon N; Clough B; McNeill E; Prockop DJ; Liu F
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):530-5. PubMed ID: 25548183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal Stem Cells Obtained from Synovial Fluid Mesenchymal Stem Cell-Derived Induced Pluripotent Stem Cells on a Matrigel Coating Exhibited Enhanced Proliferation and Differentiation Potential.
    Zheng YL; Sun YP; Zhang H; Liu WJ; Jiang R; Li WY; Zheng YH; Zhang ZG
    PLoS One; 2015; 10(12):e0144226. PubMed ID: 26649753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of human β-thalassemia induced pluripotent cell lines by reprogramming of bone marrow-derived mesenchymal stromal cells using modified mRNA.
    Varela I; Karagiannidou A; Oikonomakis V; Tzetis M; Tzanoudaki M; Siapati EK; Vassilopoulos G; Graphakos S; Kanavakis E; Goussetis E
    Cell Reprogram; 2014 Dec; 16(6):447-55. PubMed ID: 25354259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial transfer of induced pluripotent stem cell-derived mesenchymal stem cells to airway epithelial cells attenuates cigarette smoke-induced damage.
    Li X; Zhang Y; Yeung SC; Liang Y; Liang X; Ding Y; Ip MS; Tse HF; Mak JC; Lian Q
    Am J Respir Cell Mol Biol; 2014 Sep; 51(3):455-65. PubMed ID: 24738760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Induced Pluripotent Stem Cells Differentiate Into Functional Mesenchymal Stem Cells and Repair Bone Defects.
    Sheyn D; Ben-David S; Shapiro G; De Mel S; Bez M; Ornelas L; Sahabian A; Sareen D; Da X; Pelled G; Tawackoli W; Liu Z; Gazit D; Gazit Z
    Stem Cells Transl Med; 2016 Nov; 5(11):1447-1460. PubMed ID: 27400789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human iPSC-derived MSCs (iMSCs) from aged individuals acquire a rejuvenation signature.
    Spitzhorn LS; Megges M; Wruck W; Rahman MS; Otte J; Degistirici Ö; Meisel R; Sorg RV; Oreffo ROC; Adjaye J
    Stem Cell Res Ther; 2019 Mar; 10(1):100. PubMed ID: 30885246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of cell proliferation of human induced pluripotent stem cell-derived mesenchymal stem cells via ether-à-go-go 1 (hEAG1) potassium channel.
    Zhang J; Chan YC; Ho JC; Siu CW; Lian Q; Tse HF
    Am J Physiol Cell Physiol; 2012 Jul; 303(2):C115-25. PubMed ID: 22357737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Effects of Mesenchymal Stem Cells Derived From Bone Marrow, Umbilical Cord Blood, and Pluripotent Stem Cells in a Mouse Model of Chemically Induced Inflammatory Bowel Disease.
    Kagia A; Tzetis M; Kanavakis E; Perrea D; Sfougataki I; Mertzanian A; Varela I; Dimopoulou A; Karagiannidou A; Goussetis E
    Inflammation; 2019 Oct; 42(5):1730-1740. PubMed ID: 31227956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation, Characterization, and Multilineage Potency of Mesenchymal-Like Progenitors Derived from Equine Induced Pluripotent Stem Cells.
    Lepage SI; Nagy K; Sung HK; Kandel RA; Nagy A; Koch TG
    Stem Cells Dev; 2016 Jan; 25(1):80-9. PubMed ID: 26414480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of Mesenchymal Stem Cells from Human Induced Pluripotent Stem Cells Results in Downregulation of c-Myc and DNA Replication Pathways with Immunomodulation Toward CD4 and CD8 Cells.
    Wang LT; Jiang SS; Ting CH; Hsu PJ; Chang CC; Sytwu HK; Liu KJ; Yen BL
    Stem Cells; 2018 Jun; 36(6):903-914. PubMed ID: 29396902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.